The Novita Healthcare Ltd (ASX: NHL) share price is down 7% to 9.1 cents today, but up around 8x from 1.1 cents on October 23 after the biotech handed investors some big news.
On October 24 hardly known Novita told investors its TALi Detect (digital attention deficit screening program) had been approved for commercial use by the U.S. healthcare regulator the FDA.
Effectively US medical professionals using Tali Detect can also now apply for cost reimbursement from U.S. healthcare insurers or public players.
The share price was so responsive to the news as Novita is a penny stock where small price movements represent large percentage swings in value.
For example a penny stock valued at 3 cents only has to climb 3 cents to deliver traders a 100% return. Whereas a $30 stock has to climb 3,000 cents to deliver the same return.
This is why penny or micro-cap stocks attract a lot of love from day or momentum traders simply looking to turn a quick profit regardless of valuation or fundamentals.
After all if you can make a 100% in a day you can see why many are tempted to chance their arm day trading. However, it’s not a wealth-building strategy I’d recommend myself.
Back to Novita
For the quarter ending September 30 2019 Novita posted ‘cash receipts’ of just $15,00o for an operating loss of $757,000. At the period end it had $1.45 million cash on hand with a forecast for an operating cash outflow around $767,000 for the December quarter.
As such it looks likely it’ll have to undertake some capital management activities soon enough that could include a placement, warrants, capital raising, or debt funding.
You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.
So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!
Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...
While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...
Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.
You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!
You can find Tom on Twitter @tommyr345
The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.